Krystal Biotech Competitors and Similar CompaniesClear all

Krystal Biotech's competitors and similar companies include Vertex Pharmaceuticals, Genentech, Cipla and Mankind Pharma.

	Krystal Biotech Krystal Biotech is a clinical-stage gene therapy company using its proprietary Skin TARgeted Delivery (STAR-D) platform to develop treatments for skin diseases.	Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.	Mankind Pharma Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines.
Founding Date	Founding Date 2017	Founding Date 1989	Founding Date 1976	Founding Date 1935	Founding Date 1995
Type	Type Public	Type Public	Type Subsidiary	Type Public	Type Private
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Pittsburgh, US HQ Boston, US	Locations Boston, US HQ St Leonards, AU Wien, AT Bruxelles, BE São Paulo, BR Toronto, CA Praha, CZ see more	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more	Locations New Delhi, IN HQ
Employees	Employees 7547% increase	Employees 5,40013% increase	Employees 18,077	Employees 27,764	Employees 16,2532% increase
Valuation ($)	Valuation ($) 5.1 b	Valuation ($) 121.4 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $389.1m (FY, 2025)	Revenue (est.) $12b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ₹277.1b (FY, 2026)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $1.7b (FY, 2025)	Cost of goods N/A	Cost of goods ₹95.5b (FY, 2026)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $10.4b (FY, 2025)	Gross profit N/A	Gross profit ₹195b (FY, 2026)	Gross profit N/A
Net income	Net income $204.8m (FY, 2025)	Net income N/A	Net income N/A	Net income ₹38.7b (FY, 2026)	Net income N/A
Operating ⚠
Products	Products N/A	Products 6 (FY, 2022)	Products N/A	Products 1.5 k (FY, 2024)	Products N/A
Funding
Total funding raised	Total funding raised $ 11.3m	Total funding raised $ 2.4m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 239m